Thrombolysis in deep venous thrombosis

Fletcher AP , Alkjaersig N. , Sherry S. Fibrinolytic mechanisms and the development of thrombolytic therapy. Am J Med 1962; 33: 738.

Marder VJ The use of thrombolytic agents: choice of patient, drug administrations, laboratory monitoring. Ann Intern Med 1979; 90: 802.

Francis CW , Marder VJ Mechanisms of fibrinolysis. In: Williams WJ , Beutler E , Erselv AJ et al. eds, Haematology, third edition, New York: McGraw-Hill, 1983: 1266.

Tillett WS , Garner RL Fibrinolytic activity of hemolytic streptococci. J Exp Med 1933; 58: 485.

White WF , Barlow GH , Mozen MM The isolation and characterization of plasminogen activators (urokinase) from human urine. Biochemistry 1966; 5: 2160.

Bernik MB , Kwaan HC Plasminogen activator activity in cultures from human tissue: an immunological and histochemical study. J Clin Invest 1969 ; 48: 1740.

Zamarron C. , Lijnen HR, Van Heof B, Collen D. Biological and thrombolytic properties of proenzyme and active forms of human urokinase. I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinase obtained from human urine or by recombinant DNA technology. Thromb Haemost 1984; 52: 19.

Trübestein G. Fibrinolytische Therapie, Indikation und Durchführung . Dtsch Med Wochenschr 1985; 11: 1417.

Pennica D. , Holmes WE , Kohr WJ Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 1983; 301: 214.

Müllertz S. Plasminogen activator in spontaneously active human blood. Proc Soc Exp Biol Med 1953; 82: 291.

Sobel BE , Gross RW , Robison AK Thrombolysis, clot selectivity, and kinetics. Circulation 1984; 70: 160.

Topol EJ , Bell WR , Weisfeldt ML Coronary thrombolysis with recombinant tissue-type plasminogen activator: a hematologic and pharmacologic study. Ann Intern Med 1985; 103: 837.

Summaria L. , Boreisha IG , Wohl RC , Robbins KC Recombinant human Lys-plasmin and the Lys-plasmin-streptokinase complex. J Biol Chem 1979; 254: 6811.

Staniforth DH , Smith Rag , Hibbs M. Streptokinase and anisolayted streptokinase plasminogen complex - their action on haemostasis in human volunteers. Eur Clin Pharmacol 1983; 24: 751.

Hirsh J. , O'Sullivan EF , Martin M. Evaluation of a standard dosage schedule with streptokinase. Blood 1970: 35: 341.

Marder VJ , Bell WR Fibrinolytic therapy. In: Kollman RW , Hirsh J , Marder VJ , Salzmann EW eds, Haemostasis and thrombosis , Lippincott, 1987: 1393.

Widmer LK , Zemp E. , Bieland L. , Widmer Mdh. Zur Indikation der Fibrinolyse tiefer Venenthrombosen. In: Weber J, Mayer eds, Funktionelle Phlebologie , Stuttgart, New York: Thieme, 1990: 503.

van de Loo JC , Asbeck F. Thrombolytische Therapie. In: Klinik der Gegenwart, München: Urban und Schwarzenberg, 1973: 261.

Tilsner V. Nebenwirkungen. In: Streptokinasetherapie bei chronisch arteriellen Verschlußkrankheiten, Marburg: Medizinische Verlagsgesellschaft, 1975.

Schulman S. , Lockner D. , Granquvist S. , Bratt G. , Paul C. , Nyman D. A comparative randomized trial of low dose versus high dose streptokinase in deep vein thrombosis of the thigh. Thromb Haemost 1984; 51: 261.

Six P. , Marbet GA , Walter D. , Nyman F. , Duckert F. Nebenwirkungen bei verschiedenen Thrombolysemethoden. In: Neuhaus K , Duckert F eds, Blutgerinnung und Antikoagulation, Stuttgart : Schattauer, 1976: 111.

Goldhaber SZ , Buring JE , Lipnick RJ , Hennekens CH Pooled analysis of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med 1984; 76: 393.

Kakkar VV , Sagar S. , Lewis M. Treatment of deep vein thrombosis with intermittent streptokinase and plasminogen infusion. Lancet 1975; ii: 674.

Schulman S. , Lockner D. , Granquvist S. , Bratt G. , Paul C. , Nyman D. A comparative randomized trial of low dose versus high dose streptokinase in deep vein thrombosis of the thigh. Thromb Haemost 1984; 51: 261.

Marbert GA , Eichlisberger R. , Ducker F. et al. Sequential treatment of deep leg vein thrombosis with porcine plasmin and low dose streptokinase. Thromb Haemost 1982; 48: 190.

Martin M , Fiebach BJO eds. Die Kurzzeitlyse mit ultrahohen Streptokinase Dosierung zur Behandlung peripherer Arterien- und Venenverschlüsse. Bern: Huber, 1988.

D'Angelo A. , Mannucci PM Outcome of treatment of deep-vein thrombosis with urokinase: relationship of dosage, duration of therapy, age of the thrombus and laboratory changes . Thromb Haemost 1984; 51: 236.

van de Loo JC , Kriessmann A. , Trübestein G. Controlled multicenter pilot study of urokinase, heparin and streptokinase in deep vein thrombosis. Thromb Haemost 1983; 50: 660.

Greul W. , Tilsner V. Thrombolysis with urokinase in arterial and venous thrombosis. In: Paoletti R , Sherry S eds, Thrombosis and urokinase, London: Academic Press, 1977: 235.

Tilsner V. , Greuel W. Thrombolytic therapy; agents indications, clinical performance, side effects . Angiology 1978; 16: 296.

Turpie Agg , Jay RM , Carter CJ , Hirsh J. A randomized trial of recombinant tissue plasminogen activator for the treatment of proximal deep vein thrombosis (Abstract). Circulation 1985; II-72.

Zimmerman R. , Horn A. , Harenberg J. , Diehm C. , Müller-Bûhl U. , Kübler W. Thrombolysetherapie der tiefen venösen Thrombose mit rt-PA. Klin Wochenschr 1988; 66(suppl XII): 137.

Goldhaber SZ , Meyerovitz MF , Green D. et al. Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis. Am J Med 1990; 88: 235.

Hess H. Symposium über ThrombolyseTherapie. München, Stuttgart: Springer-Verlag, 1967 .

Marder VJ Guidelines for thrombolytic therapy of deep-vein thrombosis. Prog Cardiovasc Dis 1979; 21: 327.

Duckert F. , Muller G. , Nyman D. et al. Treatment of deep vein thrombosis with streptokinase. Br Med J 1975; vmr-1: 479.

Gormsen J. , Laursen B. Treatment of acute phlebothrombosis with streptase. Acta Med Scand 1967; 181: 373.

Latallo ZS , Lopaciuk S. New approach to thrombolytic therapy: the use of defibrase in connection with streptokinase. Thrombosis, Diathesis and Haemorrhagica 1973; 56 (suppl): 253.

Marder VJ Clinical guidelines and expectations for current and future thrombolytic agents in the therapy of deep vein thrombosis. In: Mannucci PM , D'Angelo A eds, Urokinase, basic and clnical aspects, London: Academic Press, 1982: 95.

The TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial: Phase I findings. N Engl J Med 1985; 312: 932.

Verstraete M. , Bernard R. , Bory M. Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Lancet 1985; i: 842.

Kernohan RJ , Todd C. Heparin therapy in thromboembolic disease . Lancet 1966; i: 621.

The Urokinase Pulmonary Embolism Trial: a national cooperative study, American Heart Association Monograph, Number 39. Circulation 1973; 47 (suppl 2): II-1-II-108.

Coller SC Platelets and thrombolytic therapy. N Engl J Med 1990; 322: 33.

National Institutes of Health Consensus Panel: thrombolytic therapy in thrombosis. 1980; 93: 141.

Arnesen H. , Hoiseth A. , Ly B. Streptokinase or heparin in the treatment of deep vein thrombosis. Acta Med Scand 1982; 65: 211.

Elliot MS , Immelman EJ , Jeffrey P. A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis. An interim report of a prospective trial . Br J Surg 1979; 66: 838.

Kakkar VV , Lawrence D. Hemodynamic and clinical assessment after therapy for acute deep vein thrombosis. A prospective study. Am J Surg 1985; 150: 54.

Common HH , Seaman AJ , Rösch J. , Porter JM , Dotter C. Deep vein thrombosis treated with streptokinase or heparin: follow-up of a randomized study. Angiology 1976; 27: 645.

Widmer LK , Brandenberg E. , Schmitt HE et al. Zum Schicksal des Patienten mit tiefrer Venenthrombose. Dtsch Med Wochenschr 1985; 110: 993.

Watz R. , Savidge GF Rapid thrombolysis and preservation of valvular venous function in high deep vein thrombosis. Acta Med Scand 1979; 205: 293.

Kakkar VV , Howe CT , Laws JW , FLanc C. Late results of treatment of deep vein thrombosis. Br Med J 1969; vmr-1: 810.

Bieger R. , Boekhout-Mussert RJ , Hohmann F. , Loeliger EA Is streptokinase useful in the treatment of deep vein thrombosis? Acta Med Scand 1976; 199: 81.

Aldrich MS , Sherman SA , Greenberg HS Cerebrovascular complications of streptokinase infusion. JAMA 1985; 253: 1777.

Coon WW , Willis PW Thromboembolic complications during anti-coagulant therapy. Arch Surg 1972; 105: 209.

Hull R. , Delmore T. , Genton E. et al. Warfarin sodium versus low dose heparin in the long term treatment of venous thrombosis. N Engl J Med 1979; 301: 855.

Browse NL , Lea Thomas M , Solan MJ , Young AE Prevention of recurrent pulmonary embolism. Br Med J 1969; 3: 382.

Widmer LK , Madar G. , Widmer MTh , Schmitt HE , Duckert E. Tiefe Thromboplebitis. In: Ehringer H ed, Akute tiefe Becken-und Beinvenenthrombosen, (Aktuelle Probleme in der Angiologie, Bd. 33.), Bern: Huber, 1977.

Browse LN , Burnand KG , Thomas ML eds. Diseases of the veins. London: Edward Arnold, 1988: 501.